236 related articles for article (PubMed ID: 26348973)
1. Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?
Iyer S; Kumar M; Reiff MI; Stein MT
J Dev Behav Pediatr; 2015 Sep; 36(7):549-51. PubMed ID: 26348973
[TBL] [Abstract][Full Text] [Related]
2. Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?
Iyer S; Kumar M; Reiff MI; Stein MT
J Dev Behav Pediatr; 2017; 38 Suppl 1():S60-S62. PubMed ID: 28141724
[TBL] [Abstract][Full Text] [Related]
3. Can stimulant rebound mimic pediatric bipolar disorder?
Sarampote CS; Efron LA; Robb AS; Pearl PL; Stein MA
J Child Adolesc Psychopharmacol; 2002; 12(1):63-7. PubMed ID: 12014597
[TBL] [Abstract][Full Text] [Related]
4. Complex ADHD Challenging Case: When Simple Becomes Complex: Managing Clinician Bias and Navigating Challenging Family Dynamics in a 6-Year-Old Girl with ADHD and Developmental Delays.
Cervantes J; Wallace J; Helms AK; Diekroger EA; Fogler J
J Dev Behav Pediatr; 2024 Mar-Apr 01; 45(2):e181-e184. PubMed ID: 38619154
[TBL] [Abstract][Full Text] [Related]
5. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
6. "Is It Her Hormones?": Psychiatric Diagnoses and Polycystic Ovarian Syndrome.
Genovese A; Smith T; Kramer H; Augustyn M
J Dev Behav Pediatr; 2016 Jan; 37(1):103-4. PubMed ID: 26703328
[TBL] [Abstract][Full Text] [Related]
7. Juan: a 9-year-old Latino boy with ADHD.
DuPaul GJ; Pérez VH; Kuo A; Stein MT
J Dev Behav Pediatr; 2010 Apr; 31(3 Suppl):S55-9. PubMed ID: 20414077
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
9. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
[TBL] [Abstract][Full Text] [Related]
10. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
12. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
Faraone SV; Glatt SJ
J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
[TBL] [Abstract][Full Text] [Related]
14. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
[TBL] [Abstract][Full Text] [Related]
16. Severe avoidant/restrictive food intake disorder and coexisting stimulant treated attention deficit hyperactivity disorder.
Pennell A; Couturier J; Grant C; Johnson N
Int J Eat Disord; 2016 Nov; 49(11):1036-1039. PubMed ID: 27521251
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms as a side effect of the sustained release form of methylphenidate in a 7-year-old boy with attention-deficit hyperactivity disorder.
Lakić A
Vojnosanit Pregl; 2012 Feb; 69(2):201-4. PubMed ID: 22500377
[TBL] [Abstract][Full Text] [Related]
18. "More than meets the eye": when the neonatal course may impact several years out.
Dopwell F; Maypole J; Sinha B; Currier H; DeBassio W; Augustyn M
J Dev Behav Pediatr; 2014 Sep; 35(7):467-9. PubMed ID: 25127342
[TBL] [Abstract][Full Text] [Related]
19. Weeding Out the Justification for Marijuana Treatment in Patients with Developmental and Behavioral Conditions.
Nelson T; Liu YH; Bagot KS; Stein MT
J Dev Behav Pediatr; 2017; 38(6):446-448. PubMed ID: 28622159
[TBL] [Abstract][Full Text] [Related]
20. Does quality of life outweigh the cardiovascular risks of stimulant medication in a child with ADHD and hypertrophic cardiomyopathy?
Senderey E; Sousa J; Stavitsky M
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
